Servico de Saude da Regiao Autonoma Da Madeira EPERAM

At Servico de Saude da Regiao Autonoma Da Madeira EPERAM in Funchal, clinical research in digestive system diseases focuses on liver conditions such as alpha-1 antitrypsin deficiency-associated liver disease and primary biliary cholangitis. These studies are designed to assess new treatment options and better understand how therapies may slow disease progression and improve liver health.

• Alpha-1 antitrypsin deficiency-associated liver disease
• Primary biliary cholangitis
• Testing treatments aimed at reducing liver scarring and improving long-term outcomes

Work in this area also reflects interest in broader nutritional and metabolic diseases, showing a strong focus on chronic conditions that affect liver function and overall metabolism.

Research in reproductive and urinary physiological phenomena and nutritional and metabolic diseases includes studies of autosomal dominant polycystic kidney disease and chronic kidney disease. The main goal is to evaluate treatments that may help protect kidney function, reduce complications, and delay worsening of disease.

• Autosomal dominant polycystic kidney disease
• Chronic kidney disease
• Evaluating therapies that may slow kidney decline and support cardiorenal health

These trials highlight a practical focus on long-term disease management and improving patient outcomes in chronic kidney disorders.

The Serviço de Neurologia is also involved in nervous system diseases research, including studies in early-stage Parkinson’s disease. This work is centered on testing treatments that may help preserve function, manage symptoms, and potentially influence disease progression.

• Early-stage Parkinson’s disease
• Testing a therapy aimed at improving disease control in the early stages
• Exploring ways to support neurological health and patient independence

The site’s neurology activity shows an interest in therapies for progressive brain disorders where early intervention may be especially important.

Clinical trials in neoplasms at this hospital include research in metastatic non-small cell lung cancer and advanced melanoma. These studies are aimed at comparing new cancer therapies with existing treatment approaches and evaluating whether they can improve survival and disease control.

• Metastatic non-small cell lung cancer
• Previously untreated advanced melanoma
• Assessing new cancer treatments and comparing effectiveness with standard care

This oncology portfolio reflects a strong interest in expanding treatment options for advanced cancers where better outcomes are urgently needed.

Across multiple therapeutic areas, the research at Servico de Saude da Regiao Autonoma Da Madeira EPERAM includes studies that examine safety, tolerability, and real-world benefit of emerging therapies for chronic conditions. The trial portfolio spans liver, kidney, neurological, and cancer-related diseases, showing a wide clinical research footprint for a hospital-based site.

• Safety and tolerability of new therapies
• Measuring whether treatments improve clinical outcomes
• Supporting research across several chronic disease areas

With 9 trials and 5 investigators, the site contributes to research that aims to improve both diagnosis and treatment effectiveness across complex long-term illnesses.